Article Versions Notes

Kuzmich N, Andresyuk E, Porozov Y, Tarasov V, Samsonov M, Preferanskaya N, Veselov V, Alyautdin R. PCSK9 as a Target for Development of a New Generation of Hypolipidemic Drugs. Molecules. 2022; 27(2):434. https://doi.org/10.3390/molecules27020434

Kuzmich, Nikolay, Elena Andresyuk, Yuri Porozov, Vadim Tarasov, Mikhail Samsonov, Nina Preferanskaya, Valery Veselov, and Renad Alyautdin. 2022. "PCSK9 as a Target for Development of a New Generation of Hypolipidemic Drugs" Molecules 27, no. 2: 434. https://doi.org/10.3390/molecules27020434

Kuzmich, N., Andresyuk, E., Porozov, Y., Tarasov, V., Samsonov, M., Preferanskaya, N., Veselov, V., & Alyautdin, R. (2022). PCSK9 as a Target for Development of a New Generation of Hypolipidemic Drugs. Molecules, 27(2), 434. https://doi.org/10.3390/molecules27020434